Caution before canonisation: a clinical and implementation science perspective on psychedelics
Andreas Paris, Foteïni Thoma, Aikaterini Velentza, Panagiota Pavlopoulou, Giorgos Metaxas
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (55)
- Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review. 2026-07-01 · Expand citations
- Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression 2026-05-01 · Expand citations
- Psychedelic medicine: mechanisms, evidence, and translation to practice. 2026-02-23 · Expand citations
- Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds. 2025-11-01 · Expand citations
- Control Group Outcomes in Trials of Psilocybin, SSRIs, or Esketamine for Depression: A Meta-Analysis. 2025-07-01 · Expand citations
- A Scoping Review of Research in Naturalistic Studies with Psychedelics. 2025-06-28 · Expand citations
- Psychedelics and mental health: reimagining care through science, insight, and compassion. 2025-01-01 · Expand citations
- Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis. 2024-12-01 · Expand citations
- EXPRESSION OF CONCERN: Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis. 2024-05-04 · Expand citations
- Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder. 2023-06-01 · Expand citations
- Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression. 2022-11-03 · Expand citations
- United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020. 2022-01-01 · Expand citations
- Blinding and expectancy confounds in psychedelic randomized controlled trials. 2021-09-01 · Expand citations
- Trial of Psilocybin versus Escitalopram for Depression. 2021-04-15 · Expand citations
- Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer. 2020-02-01 · Expand citations
- Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies. 2011-11-01 · Expand citations
- OpenAlex W1558342067
- OpenAlex W1931781407
- OpenAlex W1961364466
- OpenAlex W1973223879
- OpenAlex W2020155291
- OpenAlex W2044858486
- OpenAlex W2115504852
- OpenAlex W2120079020
- OpenAlex W2132324173
- OpenAlex W2140092196
- OpenAlex W2143805083
- OpenAlex W2302097048
- OpenAlex W2330794397
- OpenAlex W2339018270
- OpenAlex W2552814605
- OpenAlex W2762798648
- OpenAlex W2791151206
- OpenAlex W2897623369
- OpenAlex W2997901555
- OpenAlex W3160990818
- OpenAlex W4285091545
- OpenAlex W4295997603
- OpenAlex W4366974898
- OpenAlex W4380550627
- OpenAlex W4385628167
- OpenAlex W4388732506
- OpenAlex W4393253405
- OpenAlex W4396721407
- OpenAlex W4401774886
- OpenAlex W4403255583
- OpenAlex W4403543158
- OpenAlex W4409155786
- OpenAlex W4417035652
- OpenAlex W7124304128
- OpenAlex W7127167117
- OpenAlex W7136032199
- OpenAlex W7140135983
- OpenAlex W7140287448
- OpenAlex W7161629580
Cited by — these papers cite this paper (0)
No citing papers identified in the available metadata. This does not establish that none exist.